Strickland to hold new professorship; Blind recognized by genetics society
Strickland to hold new professorship
Sidney Strickland, a professor, dean of graduate and postgraduate studies, and vice president for educational affairs at Rockefeller University, will be the first person to hold that university’s new Fisher Center named professorship for neurodegenerative disease research.
Strickland’s lab studies the contribution of vascular dysfunction to the development of Alzheimer’s disease; they found that beta-amyloid protein can promote clotting and inflammation in the brain by interacting with fibrinogen and activating coagulation factor FXII. The work has suggested new molecular mechanisms for the widely studied beta-amyloid protein to contribute to Alzheimer’s pathogenesis and has linked the disease to other common maladies of aging, such as hypertension and cardiovascular disease.
The position, funded by the Fisher Center for Alzheimer’s Research Foundation, will support research into neurodegenerative diseases. It extends the Fisher Center’s partnership with Rockefeller University; the university is also home to the foundation’s flagship lab of 40 scientists focused on Alzheimer’s disease. Strickland has been a member of the Fisher Center’s neuroscience advisory committee since 2019.
Blind recognized by GSA
Raymond D. Blind, an assistant professor at Vanderbilt University, was named in early March a member of the inaugural cohort for the Genetics Society of America’s Presidential Membership Initiative. This competitive program aims to diversify the GSA membership while providing professional-development programming and support for early-career scientists.
Blind’s lab studies how nuclear inositides and inositols regulate chromatin-bound proteins. He recently completed a two-year stint as a junior associate editor for the Journal of Lipid Research, an American Society for Biochemistry and Molecular Biology publication. (Read our short profile.)
Blind will give a talk titled “The acyl chains of phosphoinositides alter the structure and function of nuclear receptor steroidogenic factor-1” at a special session on lipid diversity and disease at the 2021 ASBMB Annual Meeting. The session will be at 2:15 p.m. Eastern on Thursday, April 29.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles
From antibiotic resistance to an antibody targeting immune cells
MOSAIC scholar Diego Pedroza got his start in chemistry, then moved to molecular biology, endocrinology and testing cancer drugs — “something that could truly make a difference.”
Ali, Falade, Usman selected for mentoring program
Bashir Ali, Omolara Falade and Olalekan Usman have been selected to participate in the Scientist Mentoring & Diversity Program for Biotechnology, which pairs ethnically diverse students and early career researchers with industry mentors.
How military forensic scientists use DNA to solve mysteries
Learn how two analysts at the Armed Forces DNA Identification Laboratory use molecular biology and genetics to identify the remains of fallen troops.
A decade of teaching the Art of Science Communication
Why now, more than ever, scientists must be able to explain what they do to non-scientists.
Of genes, chromosomes and oratorios
Jenny Graves has spent her life mapping genes and comparing genomes. Now she’s created a musical opus about evolution of life on this planet — bringing the same drive and experimentalism she brought to the study of marsupial chromosomes.
In memoriam: Margaret Fonda
She taught biochemistry in a male-dominated department at a medical school and was an ASBMB member for more than 50 years.